Skip to content
Independent analysis of NHS open data
PharmaInsight

Tocilizumab

Musculoskeletal and Joint Diseases Drugs used in rheumatic diseases and gout BNF 1001030W0
Data updated July 2025 Download CSV

Tocilizumab was dispensed in England in July 2025, with 1 items, little changed on a year earlier.

1items 0%

Dispensed in July 2025

1items

Rolling 12 months

£228

Net ingredient cost · July 2025

Figure 1. Tocilizumab: national items dispensed by month

0 1.5 3 Jan 2021 Apr 2023 Jan 2024 Aug 2024 Dec 2024 Jul 2025 1 Jan 2021: 1 Aug 2021: 1 Sep 2022: 1 Apr 2023: 3 Aug 2023: 1 Oct 2023: 1 Jan 2024: 1 Apr 2024: 1 Jul 2024: 1 Aug 2024: 2 Sep 2024: 1 Oct 2024: 1 Dec 2024: 2 Jan 2025: 1 Feb 2025: 1 Jul 2025: 1

Source: NHSBSA Prescription Cost Analysis, to July 2025

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs used in rheumatic diseases and gout
  • Presentations 1 shown
  • Average cost / item £228.28
  • Year on year Little changed on a year earlier
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, July 2025

The individual products dispensed under Tocilizumab this month.

Presentations of Tocilizumab, July 2025
Presentation BNF code Items Net ingredient cost
RoActemra 162mg/0.9ml solution for injection pre-filled pens 1001030W0BBAEAE 1 £228

Source: NHSBSA Prescription Cost Analysis · to July 2025 OGL v3.0

Where Tocilizumab is dispensed

The regions and dispensing practices with the highest Tocilizumab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Tocilizumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Tocilizumab with

Other medicines in the same BNF section, by prescribing volume.